Nanotechnology in gastrointestinal endoscopy: A primer

Abstract

Nanotechnology is the understanding, control of matter and development of engineered devices in nanometer range (1-100 nm). Nanoparticles have different physicochemical properties (small size, large surface area to volume ratio, and high reactivity) in comparison to bulk materials of the same composition. The nanotechnology has proved its usefulness in early diagnosis, proteonomics, imaging diagnostics and multifunctional therapeutics. Recent studies have shown its role in early diagnosis and targeted therapy of various gastrointestinal disorders such as hepatitis B virus and hepatitis C virus related liver disease, inflammatory bowel disease, gastric ulcer, and malignancy. Application of this technology appears promising in diagnostic and therapeutic endoscopy such as the endoscopic hemostasis of peptic ulcer bleeding, prevention of clogging of plastic stent and advance capsule endoscopy. This article will highlight the basic concepts of nanotechnology and its potential application in gastrointestinal endoscopy.

Key words

Nanotechnology - nanoparticles - nanomaterials - nanopowder - hemospray - nano-based capsule-endoscopy

• References

• 1 Terminology for nanomaterials. Publicly available specification 136. London: British Standards Institute; 2007.
• 2 Jain KK. Role of nanobiotechnology in developing personalized medicine for cancer therapy. Technol Cancer Res Treat 2005a;4:645-50.
• 3 Council of the Canadian Academies. Small is different: A science perspective on the regulatory challenges of the nanoscale. July 2008.
• 4 Thorek DL, Chen A, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006;34:23-38.
• 5 Resch-Genger U, Grabolle M, Cava-liere-Jaricot S, Nitschke R, Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 2008;5:763-75.
• 6 Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Release 2005;108:84-96.
• 7 Zolnik BS, González-Fernández A, Sadrieh N, Dobrovolskaia MA. Nanoparticles and the immune system. Endocrinology 2010;151:458-65.
• 8 Cuenca AG, Jiang HB, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006;107:459-66.
• 9 Donaldson K, Aitken R, Tran L, Stone V, Du-n R, Forrest G, et al. Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006;92:5-22.
• 10 Hussain SM, Javorina A, Schrand AM, Duhart H, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006;92:456-63.
• 11 Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A. Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 2005;16:691-707.
• 12 Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003;42:463-78.
• 13 Sarker DK. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2005;2:297-310.
• 14 Lee LJ. Polymer nano-engineering for biomedical applications. Ann Biomed Eng 2006;34:75-88.
• 15 Cherian AK, Rana AC, Jain SK. Self-assembled carbohydrate stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 2000;26:459-63.
• 16 Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995-4021.
• 17 Hirsch LR, Gobin AM, Lowery AR, Tam F, Drezek RA, Halas NJ, et al. Metal nanoshells. Ann Biomed Eng 2006;34:15-22.
• 18 Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P, Dingeldein E, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004;25:4383-91.
• 19 Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicol Lett 2008;176:1-12.
• 20 Liu Y, Pinnavaia TJ. Aluminosilicate nanoparticles for catalytic hydrocarbon cracking. J Am Chem Soc 2003;125:2376-7.
• 21 Weng J, Ren J. Luminescent quantum dots: A very attractive and promising tool in biomedicine. Curr Med Chem 2006;13:897-909.
• 22 Pagona G, Tagmatarchis N. Carbon nanotubes: Materials for medicinal chemistry and biotechnological applications. Curr Med Chem 2006;13:1789-98.
• 23 Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007;18:241-68.
• 24 West JL, Halas NJ. Applications of nanotechnology to biotechnology commentary. Curr Opin Biotechnol 2000;11:215-7.
• 25 Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003;100:13549-54.
• 26 Bagshawe KD, Sharma SK, Springer CJ, Antoniw P, Boden JA, Rogers GT. Antibody directed enzyme prodrug therapy (ADEPT) — clinical report. Dis Markers 1991;9:233-8.
• 27 Vingerhoeds MH, Haisma HJ, van MM, van de Rijt RB, Crommelin DJ, Storm G. A new application for liposomesin cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs. FEBS Lett 1993;336:485-90.
• 28 Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med 2010;363:2434-43.
• 29 Szentkuti L. Light microscopical observation in luminally administered dye, dextran, nanospheres and microsphere in pre-epithelial mucus gel layer of rat distal colon. J Control Release 1997;46:233-42.
• 30 Diamond DL, Proll SC, Jacobs JM, Chan EY, Camp DG 2^nd, Smith TD, et al. Hepatoproteomics: Applying proteomics technologies to the study of liver function and disease. Hepatology 2006;44:299-308.
• 31 Laroui H, Wilson DS, Dalmasso G, Salaita K, Murthy N, Sitaraman SV, et al. Nanomedicine in GI. Am J Physiol Gastrointest Liver Physiol 2011;300: G371-83.
• 32 Yang L, Mao H, Cao Z, Wang A, Peng X, Wang X, et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology 2009;136:1514-25.
• 33 Liu T, Zhang G, Chen YH, Chen Y, Liu X, Peng J, et al. Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth. Cancer Biol Ther 2006;5:1683-90.
• 34 Giday SA, Kim Y, Krishnamurty DM, Ducharme R, Liang DB, Shin EJ, et al. Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy 2011;43:296-9.
• 35 Sung JJ, Luo D, Wu JC, Ching JY, Chan FK, Lau JY, et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011;43:291-5.
• 36 Seitz U, Block A, Schaefer AC, Wienhold U, Bohnacker S, Siebert K, et al. Biliary stent clogging solved by nanotechnology? in vitro study of inorganic-organic sol-gel coatings for teflon stents. Gastroenterology 2007;133:65-71.
• 37 European FP6 project NEMO, Nano-Based Capsule-Endoscopy with Molecular Imaging and Optical Biopsy. [Available from: http://www.nemo-strep.org ].
• 38 VECTOR: Versatile Endoscopic Capsule for gastrointestinal TumOr Recognition and therapy project. [Available from: http://www.vector-project.com .]
• 39 Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
• 40 Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 2009;72:496-501.